Asep Medical Holdings Inc (SEPSF)
USD 0.39
(0.0%)
USD 0.39
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 25.61 Million CAD | -5.41% |
| 2022 | 27.07 Million CAD | -11.84% |
| 2021 | 30.71 Million CAD | 279646.19% |
| 2020 | 10.98 Thousand CAD | 323.28% |
| 2019 | 2594.00 CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 25.23 Million CAD | -1.49% |
| 2024 Q2 | 24.84 Million CAD | -1.52% |
| 2023 Q1 | 25.73 Million CAD | -4.97% |
| 2023 Q3 | 23.82 Million CAD | -2.31% |
| 2023 Q4 | 25.61 Million CAD | 7.51% |
| 2023 FY | 25.61 Million CAD | -5.41% |
| 2023 Q2 | 24.38 Million CAD | -5.23% |
| 2022 Q1 | 29.57 Million CAD | -3.71% |
| 2022 FY | 27.07 Million CAD | -11.84% |
| 2022 Q3 | 28.27 Million CAD | -0.85% |
| 2022 Q4 | 27.07 Million CAD | -4.22% |
| 2022 Q2 | 28.51 Million CAD | -3.59% |
| 2021 FY | 30.71 Million CAD | 279646.19% |
| 2021 Q3 | 2.43 Million CAD | 0.0% |
| 2021 Q4 | 30.71 Million CAD | 1162.45% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 10.55 Million USD | -142.682% |
| Arch Therapeutics, Inc. | 1.95 Million USD | -1207.978% |
| CSL Limited | 38.02 Billion USD | 99.933% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 80.33% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -7143.058% |
| BioStem Technologies, Inc. | 14.56 Million USD | -75.908% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 51.4% |
| Qrons Inc. | 420.00 USD | -6098158.571% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -4538.971% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 8.343% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 14.667% |
| Skye Bioscience, Inc. | 11.94 Million USD | -114.504% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -5229.791% |
| Rebus Holdings, Inc. | 5000.00 USD | -512153.72% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -3625.557% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -1108674.286% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.244% |
| Neon Bloom, Inc. | 770.64 Thousand USD | -3223.543% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 34.068% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | -254.758% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -33444.655% |
| SQZ Biotechnologies Company | 107.18 Million USD | 76.105% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | -1688.555% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -35293.748% |
| Mesoblast Limited | 667.9 Million USD | 96.165% |
| Marizyme, Inc. | 22.01 Million USD | -16.342% |
| Genus plc | 1.02 Billion USD | 97.511% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | -1785.569% |
| Pharming Group N.V. | 462.85 Million USD | 94.466% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | -673.094% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -5032.402% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -3984.958% |
| ContraFect Corporation | 20.67 Million USD | -23.858% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -6461.198% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -6601.786% |
| IMV Inc. | 31.33 Million USD | 18.259% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | -517.765% |
| MultiCell Technologies, Inc. | 126.22 USD | -20291997.924% |
| ONE Bio Corp. | 70.08 Million USD | 63.455% |
| Accustem Sciences Inc. | 939.68 Thousand USD | -2625.656% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 80.069% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -5832.79% |
| Q BioMed Inc. | 3.51 Million USD | -628.561% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 27.193% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -9702.886% |
| Biomind Labs Inc. | 73.81 Thousand USD | -34596.604% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 94.261% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | -1667.803% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | -832.613% |
| Curative Biotechnology, Inc. | 2.6 Million USD | -883.894% |
| GB Sciences, Inc. | 103.44 Thousand USD | -24660.432% |
| Alpha Cognition Inc. | 2.45 Million USD | -944.491% |
| HST Global, Inc. | 1526.00 USD | -1678319.79% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | -2492.464% |
| Halberd Corporation | 10.13 Thousand USD | -252714.984% |
| Enzolytics Inc. | 361.7 Million USD | 92.919% |
| Agentix Corp. | 261.39 Thousand USD | -9698.573% |
| Resverlogix Corp. | 8.11 Million USD | -215.622% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | -1263.915% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.436% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 46.307% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -3904.134% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -112330.034% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | -186.202% |
| AVAX Technologies, Inc. | 7.37 Million USD | -247.189% |
| Zenith Capital Corp. | 7410.00 USD | -345550.283% |
| Ember Therapeutics, Inc. | 184.00 USD | -13919838.043% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -7859.046% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -9699.623% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | -2660.104% |
| Kadimastem Ltd | 2.3 Million USD | -1011.623% |
| Helix BioMedix, Inc. | 3.02 Million USD | -746.676% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -44760.556% |
| LadRx Corporation | 2.3 Million USD | -1009.792% |
| Cell Source, Inc. | 195.17 Thousand USD | -13023.203% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -7143.058% |
| NovAccess Global Inc. | 62.24 Thousand USD | -41046.199% |
| Affymax, Inc. | 7.44 Million USD | -244.118% |
| Itoco Inc. | 1.4 Million USD | -1729.383% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -26675.548% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -24062.911% |
| Mobile Lads Corp. | 52.00 USD | -49255065.385% |
| CytoDyn Inc. | 11.13 Million USD | -129.999% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -17814.477% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -143147.685% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -6544.517% |
| SYBLEU INC | 330.46 Thousand USD | -7650.428% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -6155.816% |
| International Stem Cell Corporation | 5.39 Million USD | -375.189% |
| Bioxytran, Inc. | 137.63 Thousand USD | -18508.732% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | -70.73% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | -54.489% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -32321.122% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | -2862.11% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | -240.73% |
| Neutra Corp. | 2851.00 USD | -898275.517% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 20.963% |
| PureTech Health plc | 693.97 Million USD | 96.309% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | -217.339% |
| IXICO plc | 15.84 Million USD | -61.656% |
| IntelGenx Technologies Corp. | 8.28 Million USD | -209.257% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 75.211% |
| CSL Limited | 38.02 Billion USD | 99.933% |
| Cellectis S.A. | 333.99 Million USD | 92.331% |